Results for tag: "Tysabri"

Tysabri is a drug used to treat multiple sclerosis (MS) and Crohn's disease. It is a monoclonal antibody that works by blocking the action of a protein called alpha-4-integrin, which is involved in the inflammatory process. Tysabri is a central nervous system (CNS) drug, meaning it is used to treat diseases of the brain and spinal cord. It is administered intravenously and is usually given once every four weeks. Tysabri is a relatively new drug, having been approved by the U.S. Food and Drug Administration (FDA) in 2004. It is used to treat both relapsing-remitting MS and Crohn's disease, and is considered to be a highly effective treatment for both conditions. The Tysabri market is made up of a number of companies, including Biogen, Elan Pharmaceuticals, and Genentech. These companies are involved in the research, development, and marketing of Tysabri. They are also responsible for the production and distribution of the drug. Show Less Read more